- Home
- SNPX vs SNES Comparison
SNPX vs SNES Comparison
Compare SNPX & SNES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNPX
- SNES
- Stock Information
- Founded
- SNPX 2012
- SNES 2004
- Country
- SNPX United States
- SNES United States
- Employees
- SNPX N/A
- SNES N/A
- Industry
- SNPX Medicinal Chemicals and Botanical Products
- SNES Agricultural Chemicals
- Sector
- SNPX Health Care
- SNES Industrials
- Exchange
- SNPX Nasdaq
- SNES Nasdaq
- Market Cap
- SNPX 3.1M
- SNES 2.9M
- IPO Year
- SNPX N/A
- SNES 2016
- Fundamental
- Price
- SNPX $2.12
- SNES $1.95
- Analyst Decision
- SNPX Strong Buy
- SNES Strong Buy
- Analyst Count
- SNPX 1
- SNES 1
- Target Price
- SNPX $14.00
- SNES $10.00
- AVG Volume (30 Days)
- SNPX 11.9K
- SNES 37.9K
- Earning Date
- SNPX 05-14-2025
- SNES 05-08-2025
- Dividend Yield
- SNPX N/A
- SNES N/A
- EPS Growth
- SNPX N/A
- SNES N/A
- EPS
- SNPX N/A
- SNES N/A
- Revenue
- SNPX N/A
- SNES $1,857,000.00
- Revenue This Year
- SNPX N/A
- SNES $130.53
- Revenue Next Year
- SNPX N/A
- SNES $80.00
- P/E Ratio
- SNPX N/A
- SNES N/A
- Revenue Growth
- SNPX N/A
- SNES 55.66
- 52 Week Low
- SNPX $1.84
- SNES $1.30
- 52 Week High
- SNPX $5.38
- SNES $9.80
- Technical
- Relative Strength Index (RSI)
- SNPX 37.61
- SNES 49.49
- Support Level
- SNPX $1.93
- SNES $1.30
- Resistance Level
- SNPX $2.29
- SNES $1.75
- Average True Range (ATR)
- SNPX 0.18
- SNES 0.20
- MACD
- SNPX 0.01
- SNES 0.07
- Stochastic Oscillator
- SNPX 39.63
- SNES 75.58
About SNPX Synaptogenix Inc.
Synaptogenix Inc is a biopharmaceutical company with product candidates in pre-clinical and clinical development. It is principally focused on developing a product platform based upon a drug candidate called bryostatin for the treatment of Alzheimer's disease, which is in the clinical testing stage. It is also evaluating bryostatin for other neurodegenerative or cognitive diseases and dysfunctions, such as Fragile X syndrome, Multiple Sclerosis, and Niemann-Pick Type C disease, which have undergone pre-clinical testing.
About SNES SenesTech Inc.
SenesTech Inc is a United States-based biotech platform and research company engaged in developing technology for managing animal pest populations through fertility control. The company provides its solutions to the animal market, commercial markets, and food markets. It currently has two product lines of fertility control products: ContraPest and Evolve.